echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Medical device sector last year fruitful three major investment main line exposure

    Medical device sector last year fruitful three major investment main line exposure

    • Last Update: 2020-05-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    , net profit has all increased, both in scale and at a considerable rateoverall solid growthinFrom the disclosed transcripts, the performance of pharmaceutical companies in 2013 basically continued the steady growth trend in 2012in terms of net profit attributable to shareholders of listed companies, there are seven companies with growth rates of more than 100 per cent, namely 、、、。Jiaying Pharmaceuticals' net profit in 2012 was only 7.56 million yuan, but in 2013 it ran a 743 percent increaseAfter the company completed its acquisition of 64.47 percent of Sands Pharmaceuticals, profitability improved immediately, with a net profit of 139 million yuanNanjing Pharma achieved a net profit of 38.6807 million yuan in 2013, the highest growth rate, but still lost 16.8028 million yuan after deduction"To fully promote the strategic cooperation project with the Joint Bozhi, transfer foreign investors are prohibited from entering the industry and non-main business subsidiary equity, invigorating idle and inefficient assets." "It was the main driver of the significant increase in the company's net profitin addition, there are 18 companies with a growth rate of 40-99 per cent, of which seven, including 、、、、、, have been or are in the process of restructuringfor themedical devicemerger and acquisition boom, Shanghai Securities pointed out in the research report,medical deviceindustry will gradually enter the survival of the fittest, merger and acquisition of the climax period, the industry's leading enterprises will benefit from the increase in industrial concentration, listed companies are expected to rely on capital strength in the industry mergers and acquisitions to winMedical device companies that have the conditions for mergerand and restructuring are expected to use this magic weapon to help themselves to grow fasterthe three main investment lines
    "In 2014, thepharmaceutical industrythree main lines of investment: first, medical services, such as private hospitals; "Several pharmaceutical investors told China Securities News reporter" the recent "medical sector has a significant feature, the focus of funds in medical services, medical devices, pharmaceutical stocks abandonedJiang Guangze, a veteran pharmaceutical investor, said the domestic healthcare industry will continue to maintain a high growth trendIn the future, with the break of the monopoly pattern of the three major hospitals and the entry of social capital, more and more community hospitals will be more and more, private medical institutions will flourish, mainly high-end routes and specialization of two routesJiang Guangze's view was echoed by another fund manager, Meng LiningMeng Lining told China Securities News that in 2014 the investment community is not optimistic about the future of the pharmaceutical industry, mainly because: first, the situation of combating pharmaceutical commercial bribery is becoming increasingly serious;Meng Lining has shown a strong interest in the medical device industryIn fact, since August 2013, the trend of the medical device industry is very bullishMeng Lining said that although the state three orders five-shen drugs can not be abused, but also do everything possible to lower drug prices, but the "abuse" of medical devices and the price is inflated, there is no way to reasonably stopin addition, recently Apple, Samsung and other tech giants have entered smart medicine, become the "detonating" mobile medical fuseSeveral fund managers to China Securities News reporter analysis, medical device stoking and high-end will become the industry's development trend"The core part of mobile healthcare is wearables, but there are too few high-quality mobile healthcare investment targets in the A-share market at the moment, and the concept can only be hypedMr Menlining said(Responsible Editor: DF060)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.